BCM
WVE icon

BlueCrest Capital Management’s Wave Life Sciences WVE Stock Holding History

BlueCrest Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,983
Closed -$349K – 1461
2018
Q3 		$349K Buy
+6,983
New +$315K 0.01% 957

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlueCrest Capital Management's WVE Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Wave Life Sciences (WVE) in Q4 2018, closing a stake of 6,983 shares — an estimated $349K sold.

BlueCrest Capital Management first reported a position in WVE in Q3 2018 and held it in 1 quarter. The position peaked at $349K in Q3 2018. 92 funds tracked by Wall St. Rank hold WVE as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Wave Life Sciences position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 6,983 Wave Life Sciences shares in Q4 2018, an estimated $349K.
  • BlueCrest Capital Management first reported a position in Wave Life Sciences in Q3 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's Wave Life Sciences position peaked at $349K in Q3 2018.
  • 92 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.